{"title":"补充维生素D对接受饮食治疗的妊娠期糖尿病患者血糖控制、胰岛素敏感性和妊娠结局的影响","authors":"Shiwen Yu, Xiaolin Yu, Furong Li","doi":"10.1186/s41043-025-00969-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study aims to evaluate the effects of vitamin D supplementation on glycemic control, insulin sensitivity, and pregnancy outcomes in patients with gestational diabetes mellitus (GDM) undergoing dietary therapy.</p><p><strong>Methods: </strong>This is a retrospective cohort study that included 98 patients diagnosed with GDM according to the IADPSG criteria. Patients were divided into two groups based on vitamin D supplementation: the Vitamin D group (n = 49) and the Control group (n = 49). The Vitamin D group received 400 IU of vitamin D daily until delivery. All patients followed a standardized dietary management plan. The primary outcome was the time to achieve glycemic control. Secondary outcomes included changes in HbA1c, HOMA-IR, LDL-C, hs-CRP, MDA, and pregnancy and neonatal outcomes. Propensity score matching (PSM) was used to adjust for baseline differences, and statistical analyses were performed using SPSS version 28.0.</p><p><strong>Results: </strong>A total of 98 patients (49 per group) were included after propensity score matching (PSM), with similar baseline characteristics between groups (all P > 0.05), except for higher gestational edema scores in the control group (P = 0.001). The Vitamin D group achieved glycemic control faster than the control group (adjusted HR = 2.30, 95% CI 1.50-3.52, P < 0.001) and required less insulin (β = -0.11 U/kg/day, 95% CI -0.14 to -0.08, P < 0.001). Significant improvements were observed in key metabolic and inflammatory markers, including HbA1c, fasting blood glucose, 2-hour postprandial glucose, HOMA-IR, LDL-C, hs-CRP, MDA, BMI, and gestational edema score (all P < 0.001), with no change in mid-upper arm circumference. The Vitamin D group also had significantly lower risks of pregnancy complications, adverse outcomes, and neonatal issues (P < 0.05), including reduced rates of pregnancy-induced hypertension, fetal distress, and postpartum hemorrhage.</p><p><strong>Conclusion: </strong>Vitamin D supplementation significantly improves glycemic control, enhances insulin sensitivity, and positively impacts pregnancy outcomes in patients with gestational diabetes. Vitamin D supplementation should be considered in the management of GDM.</p>","PeriodicalId":15969,"journal":{"name":"Journal of Health, Population, and Nutrition","volume":"44 1","pages":"194"},"PeriodicalIF":2.4000,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12160425/pdf/","citationCount":"0","resultStr":"{\"title\":\"Effect of vitamin D supplementation on glycemic control, insulin sensitivity, and pregnancy outcomes in gestational diabetes patients undergoing dietary therapy.\",\"authors\":\"Shiwen Yu, Xiaolin Yu, Furong Li\",\"doi\":\"10.1186/s41043-025-00969-1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>This study aims to evaluate the effects of vitamin D supplementation on glycemic control, insulin sensitivity, and pregnancy outcomes in patients with gestational diabetes mellitus (GDM) undergoing dietary therapy.</p><p><strong>Methods: </strong>This is a retrospective cohort study that included 98 patients diagnosed with GDM according to the IADPSG criteria. Patients were divided into two groups based on vitamin D supplementation: the Vitamin D group (n = 49) and the Control group (n = 49). The Vitamin D group received 400 IU of vitamin D daily until delivery. All patients followed a standardized dietary management plan. The primary outcome was the time to achieve glycemic control. Secondary outcomes included changes in HbA1c, HOMA-IR, LDL-C, hs-CRP, MDA, and pregnancy and neonatal outcomes. Propensity score matching (PSM) was used to adjust for baseline differences, and statistical analyses were performed using SPSS version 28.0.</p><p><strong>Results: </strong>A total of 98 patients (49 per group) were included after propensity score matching (PSM), with similar baseline characteristics between groups (all P > 0.05), except for higher gestational edema scores in the control group (P = 0.001). The Vitamin D group achieved glycemic control faster than the control group (adjusted HR = 2.30, 95% CI 1.50-3.52, P < 0.001) and required less insulin (β = -0.11 U/kg/day, 95% CI -0.14 to -0.08, P < 0.001). Significant improvements were observed in key metabolic and inflammatory markers, including HbA1c, fasting blood glucose, 2-hour postprandial glucose, HOMA-IR, LDL-C, hs-CRP, MDA, BMI, and gestational edema score (all P < 0.001), with no change in mid-upper arm circumference. The Vitamin D group also had significantly lower risks of pregnancy complications, adverse outcomes, and neonatal issues (P < 0.05), including reduced rates of pregnancy-induced hypertension, fetal distress, and postpartum hemorrhage.</p><p><strong>Conclusion: </strong>Vitamin D supplementation significantly improves glycemic control, enhances insulin sensitivity, and positively impacts pregnancy outcomes in patients with gestational diabetes. Vitamin D supplementation should be considered in the management of GDM.</p>\",\"PeriodicalId\":15969,\"journal\":{\"name\":\"Journal of Health, Population, and Nutrition\",\"volume\":\"44 1\",\"pages\":\"194\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2025-06-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12160425/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Health, Population, and Nutrition\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s41043-025-00969-1\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ENVIRONMENTAL SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Health, Population, and Nutrition","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s41043-025-00969-1","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENVIRONMENTAL SCIENCES","Score":null,"Total":0}
Effect of vitamin D supplementation on glycemic control, insulin sensitivity, and pregnancy outcomes in gestational diabetes patients undergoing dietary therapy.
Objective: This study aims to evaluate the effects of vitamin D supplementation on glycemic control, insulin sensitivity, and pregnancy outcomes in patients with gestational diabetes mellitus (GDM) undergoing dietary therapy.
Methods: This is a retrospective cohort study that included 98 patients diagnosed with GDM according to the IADPSG criteria. Patients were divided into two groups based on vitamin D supplementation: the Vitamin D group (n = 49) and the Control group (n = 49). The Vitamin D group received 400 IU of vitamin D daily until delivery. All patients followed a standardized dietary management plan. The primary outcome was the time to achieve glycemic control. Secondary outcomes included changes in HbA1c, HOMA-IR, LDL-C, hs-CRP, MDA, and pregnancy and neonatal outcomes. Propensity score matching (PSM) was used to adjust for baseline differences, and statistical analyses were performed using SPSS version 28.0.
Results: A total of 98 patients (49 per group) were included after propensity score matching (PSM), with similar baseline characteristics between groups (all P > 0.05), except for higher gestational edema scores in the control group (P = 0.001). The Vitamin D group achieved glycemic control faster than the control group (adjusted HR = 2.30, 95% CI 1.50-3.52, P < 0.001) and required less insulin (β = -0.11 U/kg/day, 95% CI -0.14 to -0.08, P < 0.001). Significant improvements were observed in key metabolic and inflammatory markers, including HbA1c, fasting blood glucose, 2-hour postprandial glucose, HOMA-IR, LDL-C, hs-CRP, MDA, BMI, and gestational edema score (all P < 0.001), with no change in mid-upper arm circumference. The Vitamin D group also had significantly lower risks of pregnancy complications, adverse outcomes, and neonatal issues (P < 0.05), including reduced rates of pregnancy-induced hypertension, fetal distress, and postpartum hemorrhage.
Conclusion: Vitamin D supplementation significantly improves glycemic control, enhances insulin sensitivity, and positively impacts pregnancy outcomes in patients with gestational diabetes. Vitamin D supplementation should be considered in the management of GDM.
期刊介绍:
Journal of Health, Population and Nutrition brings together research on all aspects of issues related to population, nutrition and health. The journal publishes articles across a broad range of topics including global health, maternal and child health, nutrition, common illnesses and determinants of population health.